Compare Amylx Pharmaceuticals Inc (AMLX) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Energy Select Sector SPDR Fund — how do they compare? Amylx Pharmaceuticals Inc trades at $23.6 (market cap $2.64B), while Energy Select Sector SPDR Fund trades at $61.02. Which is the better fit depends on your goals.
| AMLX | XLE | |
|---|---|---|
Market Cap | $2.64B | — |
Sector | Health | — |
52-Week High | $24.19 | $62.57 |
52-Week Low | $7.82 | $42.33 |
Enterprise Value | $2.39B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMLX trades at $23.66, up 4.37% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$144.74M in 2025, with negative ROE and ROA, while Q2 2026 EPS missed expectations. Key catalysts include the Phase 3 LUCIDITY trial readout for avexitide expected in late August or early September 2026, as highlighted in recent earnings calls and news.
Analyst consensus is strongly bullish with a $30.00 price target and 91% buy ratings, driven by pipeline potential. However, high cash burn, ongoing losses, and reliance on clinical trial success pose significant risks. The stock offers speculative upside if trials succeed but faces downside from operational challenges and market volatility.
XLE trades at $60.87, up 1.13% with strong technical momentum as moving averages signal bullish conditions. The energy ETF has rallied approximately 40% over the past year, driven by elevated oil prices and geopolitical tensions in the Middle East. Recent earnings from major holdings like ExxonMobil and Chevron show strong profit growth, though valuation metrics remain undisclosed in current data.
Outlook remains positive with energy sector leadership in 2026 performance, though geopolitical risks and high volatility present challenges. The ETF's low 0.08% expense ratio and concentrated exposure to oil giants offer efficient energy market access, but dependence on Middle East stability creates significant price sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
